The presentation on unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2021 to be made to analysts is enclosed for your records.

pdf

Torrent Pharmaceuticals Ltd.

26 Oct 2021

3227.95

-0.16%

Investor Presentation

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

The presentation on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2021 to be made to analysts is enclosed for your records.

pdf

Torrent Pharmaceuticals Ltd.

26 Oct 2021

3227.95

-0.16%

Investor Presentation

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

The presentation on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2021 to be made to analysts is enclosed for your records.

pdf

Torrent Pharmaceuticals Ltd.

27 Jul 2021

3227.95

-0.16%

Investor Presentation

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

The presentation on unaudited Consolidated Financial Results for the quarter ended 30th June, 2021 to be made to analysts is enclosed for your records.

pdf

Torrent Pharmaceuticals Ltd.

18 May 2021

3227.95

-0.16%

Investor Presentation

Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Presentation to analysts on Audited Financial Results for the quarter and year ended 31st March, 2021

pdf

Torrent Pharmaceuticals Ltd.

08 Feb 2021

3227.95

-0.16%

Investor Presentation

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

The presentation on unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2020 to be made to analysts is enclosed for your records.

pdf

Torrent Pharmaceuticals Ltd.

26 Oct 2020

3227.95

-0.16%

Investor Presentation

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

The presentation on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2020 to be made to analysts is enclosed for your records.

pdf

No results found